Modafinil in schizophrenia: Is the risk worth taking?

Daniel Neto, Carla Spínola, Joaquim Gago

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Schizophrenia is a severe mental disorder characterised by positive and negative symptoms. Negative symptoms are difficult to treat and there is no specific treatment. In small trials, modafinil has been studied in association with antipsychotic treatment. We present three cases of its use; two have developed positive symptoms and one developed renal impairment. Further studies are needed to assess its usefulness in schizophrenia and safety in this group of patients.

Original languageEnglish
Article numberbcr-2017-219218
JournalBMJ case reports
Publication statusPublished - Jun 2017


  • drugs: psychiatry
  • schizophrenia


Dive into the research topics of 'Modafinil in schizophrenia: Is the risk worth taking?'. Together they form a unique fingerprint.

Cite this